Compare GIL & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIL | BRKR |
|---|---|---|
| Founded | 1946 | 1960 |
| Country | Canada | United States |
| Employees | N/A | 11085 |
| Industry | Building Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 9.0B |
| IPO Year | 1999 | 2000 |
| Metric | GIL | BRKR |
|---|---|---|
| Price | $56.72 | $57.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $78.00 | $48.54 |
| AVG Volume (30 Days) | 1.5M | ★ 2.4M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.65% | 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $71.14 | $6.30 |
| Revenue Next Year | $5.20 | $3.81 |
| P/E Ratio | $23.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.55 | $28.53 |
| 52 Week High | $73.70 | $65.30 |
| Indicator | GIL | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 57.63 | 49.83 |
| Support Level | $55.16 | $54.54 |
| Resistance Level | $59.14 | $64.46 |
| Average True Range (ATR) | 1.89 | 3.06 |
| MACD | 0.32 | -0.16 |
| Stochastic Oscillator | 75.16 | 54.95 |
Gildan is a vertically integrated designer and manufacturer of basic apparel, including T-shirts, underwear, socks, and hosiery. It is a leader in blank T-shirts, sweatshirts, and other apparel to wholesalers, major clothing brands, and printers (printwear). Gildan also sells branded clothing through retail and direct-to-consumer channels, a business that has been greatly enhanced by the Hanesbrands acquisition. Gildan's brands include Hanes, Bali, Maidenform, Playtex, Gildan, American Apparel, Comfort Colors, and Goldtoe. Gildan produces most of its clothing at factories in Latin America but has been ramping up production at its new facility in Bangladesh. Incorporated in 1984, the Montreal-based company operates internationally but generated 90% of its sales in the US in 2025.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.